Brief: Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
16/05/2025 21:31
May 16 (Reuters) - Summit Therapeutics Inc SMMT.O: SUMMIT THERAPEUTICS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4) Source text: ID:nBwcbzZZva Further company coverage: SMMT.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Summit Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Intel, Victoria's Secret, Super Micro
U.S. STOCKS ON THE MOVE-Novo Nordisk, Intel, Oracle
Summit Therapeutics rebounds after pulling stock offering
Brief: Summit Therapeutics Withdraws Proposed Underwritten Public Offering Effective- SEC Filing
Summit Therapeutics falls on launching $500 mln stock offering